← Back to Clinical Trials
Recruiting NCT02994719

Gait Analysis in Neurological Disease

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Parkinson's Disease
Sponsor Beth Israel Deaconess Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2016-03-01
Completion 2026-06-20
Interventions
Anti-Parkinson medicationDeep Brain Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to investigate whether speed-dependent measures of gait can be identified in patients with neurological conditions that affect gait, particularly in subjects with parkinsonian disorders.

Eligibility Criteria

Inclusion Criteria: * Age 18-85 (for both healthy and affected subjects). * Presence of at least 2 of the following: bradykinesia, rest tremor, rigidity, postural instability (UK PD Brain Bank Criteria) (Affected subjects only). * Montreal Cognitive Assessment will be employed to determine whether subjects will need the assent of a legally authorized representative. Subjects with MOCA ≤ 21 will be consented only with the assent of the subject and informed consent of the authorized legal representative (Affected subjects only). * These may include subjects who may have indeterminate parkinsonism, when it is not clear whether they have idiopathic Parkinson's Disease versus one of the Atypical Parkinsonisms, such as Vascular Parkinsonism, Multiple System Atrophy, Progressive Supranuclear Palsy, Normal Pressure Hydrocephalus or Corticobasal Degeneration (Affected subjects only). * Subjects with assistive devices will be eligible for the study and may use them during the study (Affected sub

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}